---
title: "PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing | PACB Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283506957.md"
description: "PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing | PACB Stock News"
datetime: "2026-04-21T05:05:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283506957.md)
  - [en](https://longbridge.com/en/news/283506957.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283506957.md)
generator: "portal-rs"
---

# PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing | PACB Stock News

PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing | PACB Stock News

### Related Stocks

- [PACB.US](https://longbridge.com/en/quote/PACB.US.md)
- [OMIC.US](https://longbridge.com/en/quote/OMIC.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)

## Related News & Research

- [PacBio Cuts Outlook as SPRQ-Nx Transition Slows, Targets 2028 Cash-Flow Positivity](https://longbridge.com/en/news/296015220.md)
- [Moderna surges on trial win for cancer shot; William Blair upgrades](https://longbridge.com/en/news/296370751.md)
- [Guotai Asset Management sees liquidity boost driving China biotech, innovation drug shares higher](https://longbridge.com/en/news/296448906.md)
- [Pacific Biosciences Q2 adj. loss bigger than estimates on margin pressure](https://longbridge.com/en/news/295012410.md)
- [<![CDATA[Expanding Access to Whole-Genome Testing for Children: Q&A with Drs. Ryan Taft and Stacy Musone]]>](https://longbridge.com/en/news/281626394.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**